<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03050801</url>
  </required_header>
  <id_info>
    <org_study_id>170055</org_study_id>
    <secondary_id>17-N-0055</secondary_id>
    <nct_id>NCT03050801</nct_id>
  </id_info>
  <brief_title>Functional Connectivity as a Biomarker of rTMS</brief_title>
  <official_title>Functional Connectivity as a Biomarker of rTMS</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Institute of Neurological Disorders and Stroke (NINDS)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Institutes of Health Clinical Center (CC)</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background:&#xD;
&#xD;
      Traumatic brain injury (TBI) damages the connections between brain cells. This can lead to&#xD;
      problems like memory loss. Repetitive transcranial magnetic stimulation (rTMS) can help&#xD;
      improve connections between brain areas in healthy people. Researchers want to see if it can&#xD;
      be useful in patients with memory problems after TBI.&#xD;
&#xD;
      Objective:&#xD;
&#xD;
      To see how repetitive transcranial magnetic stimulation can be used to improve the&#xD;
      connections between parts of the brain and whether this will lead to changes in memory.&#xD;
&#xD;
      Eligibility:&#xD;
&#xD;
      Adults 18-50 years old with TBI who can speak and write in English.&#xD;
&#xD;
      Healthy volunteers the same age and English ability.&#xD;
&#xD;
      Design:&#xD;
&#xD;
      Participants will be screened with a neurological exam and may have a urine pregnancy test.&#xD;
&#xD;
      Participants with TBI will have 7-15 visits. Healthy volunteers will have 2-8 visits.&#xD;
&#xD;
      At the visits, participants will have all or some of the following:&#xD;
&#xD;
        -  MRI for about 1 hour. Participants will lie in a machine that takes pictures in a&#xD;
           magnetic field. Participants will do some memory tasks.&#xD;
&#xD;
        -  Memory and attention tasks with pictures and with a computer&#xD;
&#xD;
        -  Questions about their mental state and well-being&#xD;
&#xD;
        -  TMS: A wire coil is held on the scalp and a short electrical current passes through it.&#xD;
           Participants will hear a click and feel a pulling or twitch. They may be asked to make&#xD;
           simple movements. rTMS is repeated magnetic pulses in short bursts. They will have this&#xD;
           for about 20 minutes.&#xD;
&#xD;
      A week after the last visit, some participants will return for a memory test.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objective: To use resting state functional connectivity (FC) as a biomarker of synaptic&#xD;
      modulation by repetitive transcranial magnetic stimulation (rTMS) in paradigms intended to&#xD;
      improve memory and learning. Ancillary outcomes include the effects of rTMS on the&#xD;
      interaction between the explicit implicit memory systems.&#xD;
&#xD;
      Study population: Healthy adult volunteers&#xD;
&#xD;
      Design: The study contains two experiments. Experiment 1 is designed to establish the number&#xD;
      of rTMS sessions required to produce a meaningful change in resting parieto-hippocampal FC in&#xD;
      healthy subjects. Experiment 2 will replicate a prior experiment which used rTMS to enhance&#xD;
      the explicit memory system in healthy subjects, and look for potential effects on the&#xD;
      implicit system. This intervention will be contrasted with a negative control condition&#xD;
      (vertex stimulation) in a between-groups design.&#xD;
&#xD;
      Outcome measures: The primary outcome measure is the change in FC produced by serially&#xD;
      applied rTMS and improvement in explicit memory. We will explore whether enhancement of the&#xD;
      explicit system has effects on resting state connectivity in the implicit system and whether&#xD;
      white matter integrity predicts changes in FC in healthy subjects.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 24, 2017</start_date>
  <completion_date type="Actual">August 7, 2020</completion_date>
  <primary_completion_date type="Actual">March 10, 2020</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Functional Connectivity (FC) Changes Between the Left Hippocampus and Left Parietal Cortex</measure>
    <time_frame>Changes are calculated before and the day after rTMS</time_frame>
    <description>Transcranial Magnetic Stimulation (TMS) is a non-invasive technique which applies magnetic pulses to the brain via a coil inducing an electrical current in the brain. Stimulation is typically applied at sufficient intensity to trigger action potentials in nearby neurons.The motor threshold is defined as the minimum percentage of the stimulator output to elicit a motor evoked potential. Repetitive TMS (rTMS) was delivered at 100% of the motor evoked potential threshold with repeated magnetic pulses at a frequency of 20 Hz. Functional MRI (fMRI) measures the change in oxygenated blood in the brain; at rest these levels fluctuate over time. These fluctuations can be similar between different parts of the brain. FC is the similarity in fluctuations of these fMRI signals and suggest how strongly two regions communicate with each other. We measured how TMS can change FC between specific areas of the brain. A positive score suggests a stronger communication between regions of the brain.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Associative Memory Test Score Changes</measure>
    <time_frame>Changes are calculated before and the day after rTMS and before and 7-14 days after rTMS</time_frame>
    <description>Participants studied 20 face-word pairs, and after a short delay, were required to recall the word associated with each pair. The number of correctly remembered pairs was recorded. rTMS was administered over different regions of the brain over 3 days. The Associative Memory test was administered at baseline (within a week before the first rTMS session), 1 day after the last rTMS session, and again 7-14 days after the last rTMS session. We calculated improvements on this task by subtracting the number of successfully remembered pairs 1 day after stimulation from the number remembered at baseline (&quot;Changes one day after rTMS&quot;). We also calculated whether these improvements lasted longer by subtracting the number of successfully remembered pairs 7-14 days after stimulation from the number remembered at baseline (&quot;Changes 7-14 days after rTMS&quot;). Positive scores represent increases in associative memory.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Implicit Weather Prediction Task (WPT)</measure>
    <time_frame>Changes are calculated before and the day after rTMS, and before and 7-14 days after rTMS</time_frame>
    <description>Participants learn implicit, probabilistic relationships between stimuli and responses through feedback. 1, 2 and 3 card combinations of 4 possible cards are presented on a computer; the subject is asked to predict whether it will be rainy or fine. After each prediction, the subject receives corrective feedback. Each card is independently associated with one outcome with a fixed probability.The WPT was administered at baseline and 1 day after and 7-14 days after the last rTMS session. Scores at each time point represent the proportion of responses associated with a reward (optimal responses). We calculated improvement by subtracting the number of optimal responses 1 day after stimulation from the number at baseline (Changes one day after rTMS). We also calculated if these improvements lasted longer by subtracting the number of optimal responses 7-14 days after stimulation from the number at baseline (Changes 7-14 days after rTMS).Positive scores represent increases in implicit memory.</description>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Actual">68</enrollment>
  <condition>Traumatic Brain Injury</condition>
  <arm_group>
    <arm_group_label>Parietal Cortex rTMS stimulation - 1 day</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Experiment 1</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Parietal Cortex rTMS stimulation - 3 days</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Experiment 1</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Parietal Cortex rTMS stimulation - 4 days</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Experiment 1</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Experiment 2 - Parietal Cortex rTMS stimulation - 3 days</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Experiment 2</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Experiment 2 - Vertex rTMS stimulation - 3 days</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Experiment 2</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Experiment 2 - Prefrontal Cortex rTMS stimulation - 3 days</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Experiment 2</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>rTMS</intervention_name>
    <description>Altering the connectivity of trans-synaptic pathways</description>
    <arm_group_label>Experiment 2 - Parietal Cortex rTMS stimulation - 3 days</arm_group_label>
    <arm_group_label>Experiment 2 - Prefrontal Cortex rTMS stimulation - 3 days</arm_group_label>
    <arm_group_label>Experiment 2 - Vertex rTMS stimulation - 3 days</arm_group_label>
    <arm_group_label>Parietal Cortex rTMS stimulation - 1 day</arm_group_label>
    <arm_group_label>Parietal Cortex rTMS stimulation - 3 days</arm_group_label>
    <arm_group_label>Parietal Cortex rTMS stimulation - 4 days</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        INCLUSION CRITERIA:&#xD;
&#xD;
        Experiments 1 and 2:&#xD;
&#xD;
        Healthy individuals&#xD;
&#xD;
        Age 18-50 (inclusive)&#xD;
&#xD;
        English speaking and writing&#xD;
&#xD;
        Experiment 3:&#xD;
&#xD;
        Age 18-50 (inclusive)&#xD;
&#xD;
        English speaking and writing&#xD;
&#xD;
        History of mild to moderate TBI&#xD;
&#xD;
        Performance 1 standard deviation below age-adjusted population norms on the&#xD;
&#xD;
        CVLT-2 within the past year from the date of visit.&#xD;
&#xD;
        EXCLUSION CRITERIA:&#xD;
&#xD;
        Any current major neurological or psychiatric disorder such as (but not limited to) stroke,&#xD;
        Parkinson disease, Alzheimer disease, schizophrenia or major depression&#xD;
&#xD;
        History of seizure&#xD;
&#xD;
        Medications acting on the central nervous system&#xD;
&#xD;
        Ferromagnetic metal in the cranial cavity or eye, implanted neural stimulator, cochlear&#xD;
        implant, or ocular foreign body&#xD;
&#xD;
        Implanted cardiac pacemaker or auto-defibrillator or pump&#xD;
&#xD;
        Non-removable body piercing&#xD;
&#xD;
        Claustrophobia&#xD;
&#xD;
        Inability to lie supine for 1 hour&#xD;
&#xD;
        Pregnancy, nursing, or plans to become pregnant during the study.&#xD;
&#xD;
        Members of the NINDS Behavioral Neurology Unit (BNU)&#xD;
&#xD;
        For Experiment 2: Participation in Experiment 1&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eric M Wassermann, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Institute of Neurological Disorders and Stroke (NINDS)</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>National Institutes of Health Clinical Center</name>
      <address>
        <city>Bethesda</city>
        <state>Maryland</state>
        <zip>20892</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://clinicalstudies.info.nih.gov/cgi/detail.cgi?A_2017-N-0055.html</url>
    <description>NIH Clinical Center Detailed Web Page</description>
  </link>
  <reference>
    <citation>Wang JX, Rogers LM, Gross EZ, Ryals AJ, Dokucu ME, Brandstatt KL, Hermiller MS, Voss JL. Targeted enhancement of cortical-hippocampal brain networks and associative memory. Science. 2014 Aug 29;345(6200):1054-7. doi: 10.1126/science.1252900.</citation>
    <PMID>25170153</PMID>
  </reference>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>February 10, 2017</study_first_submitted>
  <study_first_submitted_qc>February 10, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">February 13, 2017</study_first_posted>
  <results_first_submitted>February 11, 2021</results_first_submitted>
  <results_first_submitted_qc>March 15, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">April 12, 2021</results_first_posted>
  <last_update_submitted>March 15, 2021</last_update_submitted>
  <last_update_submitted_qc>March 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Explicit Memory</keyword>
  <keyword>Implicit Memory</keyword>
  <keyword>Memory Disorder</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Injuries</mesh_term>
    <mesh_term>Brain Injuries, Traumatic</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>November 13, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/01/NCT03050801/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Healthy Volunteers with an age range of 18-50 years were recruited for participation in Experiment 1 and 2. HV participants self-referred either directly or via the NIH Clinical Research Volunteer Program. Interested participants were pre-screened over the telephone.&#xD;
Participants with Traumatic Brain Injury were not recruited for this study, as Experiment 3 was not performed.</recruitment_details>
      <pre_assignment_details>Participants were pre-screened by telephone and scheduled for consent and formal screening. Participants meeting eligibility were enrolled in the experiment. Study participants were either enrolled in Experiment 1 or 2. Experiment 1 was designed to determine the optimal number of rTMS sessions to produce a meaningful change in brain connectivity. Experiment 2 used the optimal number of rTMS sessions identified in Experiment 1, to stimulate different brain regions to study the effect on memory.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Experiment 1: Parietal Cortex rTMS Stimulation - 1 Day</title>
          <description>Experiment 1&#xD;
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Parietal Cortex over 1 day</description>
        </group>
        <group group_id="P2">
          <title>Experiment 1: Parietal Cortex rTMS Stimulation - 3 Days</title>
          <description>Experiment 1&#xD;
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Parietal Cortex over 3 days</description>
        </group>
        <group group_id="P3">
          <title>Experiment 1: Parietal Cortex rTMS Stimulation - 4 Days</title>
          <description>Experiment 1&#xD;
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Parietal Cortex over 4 days</description>
        </group>
        <group group_id="P4">
          <title>Experiment 2: Parietal Cortex rTMS Stimulation - 3 Days</title>
          <description>Experiment 2&#xD;
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Parietal Cortex over 3 days</description>
        </group>
        <group group_id="P5">
          <title>Experiment 2: Vertex rTMS Stimulation - 3 Days</title>
          <description>Experiment 2&#xD;
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Vertex, over 3 days</description>
        </group>
        <group group_id="P6">
          <title>Experiment 2: Prefrontal Cortex Stimulation</title>
          <description>Experiment 2&#xD;
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Prefrontal Cortex, over 3 days</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Experiment 1</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="13"/>
                <participants group_id="P3" count="8"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="6"/>
                <participants group_id="P3" count="6"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="7"/>
                <participants group_id="P3" count="2"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Change of experimental design</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Unable to obtain critical rTMS measure</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="2"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Experiment 2</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="21"/>
                <participants group_id="P5" count="19"/>
                <participants group_id="P6" count="4">Experiment 2 (Prefrontal Cortex Stimulation) was terminated early due to adverse events (intolerance of stimulation) in 2 of 4 participants.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="15"/>
                <participants group_id="P5" count="15"/>
                <participants group_id="P6" count="2"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="6"/>
                <participants group_id="P5" count="4"/>
                <participants group_id="P6" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="1"/>
                <participants group_id="P5" count="1"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="1"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Pregnancy</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="1"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="1"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Poor data quality</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="4"/>
                <participants group_id="P5" count="1"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Discomfort during stimulation</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Experiment 1: Parietal Cortex rTMS Stimulation - 1 Day</title>
          <description>Experiment 1&#xD;
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Parietal Cortex over 1 day</description>
        </group>
        <group group_id="B2">
          <title>Experiment 1: Parietal Cortex rTMS Stimulation - 3 Days</title>
          <description>Experiment 1&#xD;
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Parietal Cortex over 3 days</description>
        </group>
        <group group_id="B3">
          <title>Experiment 1: Parietal Cortex rTMS Stimulation - 4 Days</title>
          <description>Experiment 1&#xD;
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Parietal Cortex over 4 days</description>
        </group>
        <group group_id="B4">
          <title>Experiment 2: Parietal Cortex rTMS Stimulation - 3 Days</title>
          <description>Experiment 2&#xD;
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Parietal Cortex over 3 days</description>
        </group>
        <group group_id="B5">
          <title>Experiment 2: Vertex rTMS Stimulation - 3 Days</title>
          <description>Experiment 2&#xD;
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Vertex, over 3 days</description>
        </group>
        <group group_id="B6">
          <title>Experiment 2: Prefrontal rTMS Stimulation - 3 Days</title>
          <description>Experiment 2&#xD;
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Prefrontal Cortex over 3 days</description>
        </group>
        <group group_id="B7">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="3"/>
            <count group_id="B2" value="6"/>
            <count group_id="B3" value="6"/>
            <count group_id="B4" value="15"/>
            <count group_id="B5" value="15"/>
            <count group_id="B6" value="2"/>
            <count group_id="B7" value="47"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="6"/>
                    <measurement group_id="B4" value="15"/>
                    <measurement group_id="B5" value="15"/>
                    <measurement group_id="B6" value="2"/>
                    <measurement group_id="B7" value="47"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28.33" spread="9.24"/>
                    <measurement group_id="B2" value="23.83" spread="2.64"/>
                    <measurement group_id="B3" value="26.67" spread="3.14"/>
                    <measurement group_id="B4" value="25.60" spread="5.46"/>
                    <measurement group_id="B5" value="24.93" spread="4.40"/>
                    <measurement group_id="B6" value="21.00" spread="2.82"/>
                    <measurement group_id="B7" value="25.27" spread="4.88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="6"/>
                    <measurement group_id="B5" value="6"/>
                    <measurement group_id="B6" value="1"/>
                    <measurement group_id="B7" value="19"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="9"/>
                    <measurement group_id="B5" value="9"/>
                    <measurement group_id="B6" value="1"/>
                    <measurement group_id="B7" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="6"/>
                    <measurement group_id="B5" value="2"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="6"/>
                    <measurement group_id="B4" value="9"/>
                    <measurement group_id="B5" value="13"/>
                    <measurement group_id="B6" value="2"/>
                    <measurement group_id="B7" value="38"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="5"/>
                    <measurement group_id="B5" value="2"/>
                    <measurement group_id="B6" value="1"/>
                    <measurement group_id="B7" value="10"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="1"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="5"/>
                    <measurement group_id="B5" value="10"/>
                    <measurement group_id="B6" value="1"/>
                    <measurement group_id="B7" value="24"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="2"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="3"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Functional Connectivity (FC) Changes Between the Left Hippocampus and Left Parietal Cortex</title>
        <description>Transcranial Magnetic Stimulation (TMS) is a non-invasive technique which applies magnetic pulses to the brain via a coil inducing an electrical current in the brain. Stimulation is typically applied at sufficient intensity to trigger action potentials in nearby neurons.The motor threshold is defined as the minimum percentage of the stimulator output to elicit a motor evoked potential. Repetitive TMS (rTMS) was delivered at 100% of the motor evoked potential threshold with repeated magnetic pulses at a frequency of 20 Hz. Functional MRI (fMRI) measures the change in oxygenated blood in the brain; at rest these levels fluctuate over time. These fluctuations can be similar between different parts of the brain. FC is the similarity in fluctuations of these fMRI signals and suggest how strongly two regions communicate with each other. We measured how TMS can change FC between specific areas of the brain. A positive score suggests a stronger communication between regions of the brain.</description>
        <time_frame>Changes are calculated before and the day after rTMS</time_frame>
        <population>Healthy volunteers participants</population>
        <group_list>
          <group group_id="O1">
            <title>Experiment 1: Parietal Cortex rTMS Stimulation - 1 Day</title>
            <description>Experiment 1&#xD;
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Parietal Cortex over 1 day</description>
          </group>
          <group group_id="O2">
            <title>Experiment 1: Parietal Cortex rTMS Stimulation - 3 Days</title>
            <description>Experiment 1&#xD;
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Parietal Cortex over 3 days</description>
          </group>
          <group group_id="O3">
            <title>Experiment 1: Parietal Cortex rTMS Stimulation - 4 Days</title>
            <description>Experiment 1&#xD;
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Parietal Cortex over 4 days</description>
          </group>
          <group group_id="O4">
            <title>Experiment 2: Parietal Cortex rTMS Stimulation - 3 Days</title>
            <description>Experiment 2&#xD;
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Parietal Cortex over 3 days</description>
          </group>
          <group group_id="O5">
            <title>Experiment 2: Vertex rTMS Stimulation - 3 Days</title>
            <description>Experiment 2&#xD;
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Vertex, over 3 days</description>
          </group>
          <group group_id="O6">
            <title>Experiment 2: Prefrontal Cortex rTMS Stimulation - 3 Days</title>
            <description>Experiment 2&#xD;
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Prefrontal Cortex, over 3 days</description>
          </group>
        </group_list>
        <measure>
          <title>Functional Connectivity (FC) Changes Between the Left Hippocampus and Left Parietal Cortex</title>
          <description>Transcranial Magnetic Stimulation (TMS) is a non-invasive technique which applies magnetic pulses to the brain via a coil inducing an electrical current in the brain. Stimulation is typically applied at sufficient intensity to trigger action potentials in nearby neurons.The motor threshold is defined as the minimum percentage of the stimulator output to elicit a motor evoked potential. Repetitive TMS (rTMS) was delivered at 100% of the motor evoked potential threshold with repeated magnetic pulses at a frequency of 20 Hz. Functional MRI (fMRI) measures the change in oxygenated blood in the brain; at rest these levels fluctuate over time. These fluctuations can be similar between different parts of the brain. FC is the similarity in fluctuations of these fMRI signals and suggest how strongly two regions communicate with each other. We measured how TMS can change FC between specific areas of the brain. A positive score suggests a stronger communication between regions of the brain.</description>
          <population>Healthy volunteers participants</population>
          <units>Change in z-transformed R-value</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="6"/>
                <count group_id="O3" value="6"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="15"/>
                <count group_id="O6" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.03" spread="0.089"/>
                    <measurement group_id="O2" value="0.13" spread="0.202"/>
                    <measurement group_id="O3" value="0.02" spread="0.123"/>
                    <measurement group_id="O4" value="-0.01" spread="0.109"/>
                    <measurement group_id="O5" value="-0.05" spread="0.141"/>
                    <measurement group_id="O6" value="0.03" spread="0.088"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Associative Memory Test Score Changes</title>
        <description>Participants studied 20 face-word pairs, and after a short delay, were required to recall the word associated with each pair. The number of correctly remembered pairs was recorded. rTMS was administered over different regions of the brain over 3 days. The Associative Memory test was administered at baseline (within a week before the first rTMS session), 1 day after the last rTMS session, and again 7-14 days after the last rTMS session. We calculated improvements on this task by subtracting the number of successfully remembered pairs 1 day after stimulation from the number remembered at baseline (&quot;Changes one day after rTMS&quot;). We also calculated whether these improvements lasted longer by subtracting the number of successfully remembered pairs 7-14 days after stimulation from the number remembered at baseline (&quot;Changes 7-14 days after rTMS&quot;). Positive scores represent increases in associative memory.</description>
        <time_frame>Changes are calculated before and the day after rTMS and before and 7-14 days after rTMS</time_frame>
        <population>Experiment 1 identified the optimal number of rTMS sessions to be applied in Experiment 2. The optimal number of rTMS sessions, i.e., 3 days, was applied to different regions of the brain in Experiment 2. Therefore, only the Experiment 2 data is reported for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Experiment 2: Parietal Cortex rTMS Stimulation - 3 Days</title>
            <description>Experiment 2&#xD;
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Parietal Cortex over 3 days</description>
          </group>
          <group group_id="O2">
            <title>Experiment 2: Vertex rTMS Stimulation - 3 Days</title>
            <description>Experiment 2&#xD;
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Vertex, over 3 days</description>
          </group>
          <group group_id="O3">
            <title>Experiment 2: Prefrontal Cortex rTMS Stimulation - 3 Days</title>
            <description>Experiment 2&#xD;
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Prefrontal Cortex, over 3 days</description>
          </group>
        </group_list>
        <measure>
          <title>Associative Memory Test Score Changes</title>
          <description>Participants studied 20 face-word pairs, and after a short delay, were required to recall the word associated with each pair. The number of correctly remembered pairs was recorded. rTMS was administered over different regions of the brain over 3 days. The Associative Memory test was administered at baseline (within a week before the first rTMS session), 1 day after the last rTMS session, and again 7-14 days after the last rTMS session. We calculated improvements on this task by subtracting the number of successfully remembered pairs 1 day after stimulation from the number remembered at baseline (&quot;Changes one day after rTMS&quot;). We also calculated whether these improvements lasted longer by subtracting the number of successfully remembered pairs 7-14 days after stimulation from the number remembered at baseline (&quot;Changes 7-14 days after rTMS&quot;). Positive scores represent increases in associative memory.</description>
          <population>Experiment 1 identified the optimal number of rTMS sessions to be applied in Experiment 2. The optimal number of rTMS sessions, i.e., 3 days, was applied to different regions of the brain in Experiment 2. Therefore, only the Experiment 2 data is reported for this outcome measure.</population>
          <units>Change in proportion of remembered pairs</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Changes one day after rTMS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.08" spread="0.133"/>
                    <measurement group_id="O2" value="0.01" spread="0.166"/>
                    <measurement group_id="O3" value="0.03" spread="0.035"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Changes 7-14 days after rTMS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.08" spread="0.173"/>
                    <measurement group_id="O2" value="0.02" spread="0.149"/>
                    <measurement group_id="O3" value="0.13" spread="0.071"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Implicit Weather Prediction Task (WPT)</title>
        <description>Participants learn implicit, probabilistic relationships between stimuli and responses through feedback. 1, 2 and 3 card combinations of 4 possible cards are presented on a computer; the subject is asked to predict whether it will be rainy or fine. After each prediction, the subject receives corrective feedback. Each card is independently associated with one outcome with a fixed probability.The WPT was administered at baseline and 1 day after and 7-14 days after the last rTMS session. Scores at each time point represent the proportion of responses associated with a reward (optimal responses). We calculated improvement by subtracting the number of optimal responses 1 day after stimulation from the number at baseline (Changes one day after rTMS). We also calculated if these improvements lasted longer by subtracting the number of optimal responses 7-14 days after stimulation from the number at baseline (Changes 7-14 days after rTMS).Positive scores represent increases in implicit memory.</description>
        <time_frame>Changes are calculated before and the day after rTMS, and before and 7-14 days after rTMS</time_frame>
        <population>Experiment 1 identified the optimal number of rTMS sessions to be applied in Experiment 2. The optimal number of rTMS sessions, i.e., 3 days, was applied to different regions of the brain in Experiment 2. Therefore, only the Experiment 2 data is reported for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Experiment 2: Parietal Cortex rTMS Stimulation - 3 Days</title>
            <description>Experiment 2&#xD;
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Parietal Cortex over 3 days</description>
          </group>
          <group group_id="O2">
            <title>Experiment 2: Vertex rTMS Stimulation - 3 Days</title>
            <description>Experiment 2&#xD;
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Vertex, over 3 days</description>
          </group>
          <group group_id="O3">
            <title>Experiment 2: Prefrontal Cortex rTMS Stimulation - 3 Days</title>
            <description>Experiment 2&#xD;
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Prefrontal Cortex, over 3 days</description>
          </group>
        </group_list>
        <measure>
          <title>Implicit Weather Prediction Task (WPT)</title>
          <description>Participants learn implicit, probabilistic relationships between stimuli and responses through feedback. 1, 2 and 3 card combinations of 4 possible cards are presented on a computer; the subject is asked to predict whether it will be rainy or fine. After each prediction, the subject receives corrective feedback. Each card is independently associated with one outcome with a fixed probability.The WPT was administered at baseline and 1 day after and 7-14 days after the last rTMS session. Scores at each time point represent the proportion of responses associated with a reward (optimal responses). We calculated improvement by subtracting the number of optimal responses 1 day after stimulation from the number at baseline (Changes one day after rTMS). We also calculated if these improvements lasted longer by subtracting the number of optimal responses 7-14 days after stimulation from the number at baseline (Changes 7-14 days after rTMS).Positive scores represent increases in implicit memory.</description>
          <population>Experiment 1 identified the optimal number of rTMS sessions to be applied in Experiment 2. The optimal number of rTMS sessions, i.e., 3 days, was applied to different regions of the brain in Experiment 2. Therefore, only the Experiment 2 data is reported for this outcome measure.</population>
          <units>Change in proportion of optimal response</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Changes one day after rTMS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.03" spread="0.158"/>
                    <measurement group_id="O2" value="0.06" spread="0.196"/>
                    <measurement group_id="O3" value="0.06" spread="0.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Changes 7-14 days after rTMS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.02" spread="0.143"/>
                    <measurement group_id="O2" value="0.02" spread="0.156"/>
                    <measurement group_id="O3" value="0.01" spread="0.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events were collected during and immediately after study procedures. Participants experiencing adverse events at completion of study procedures, were followed until AE resolution.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Experiment 1: Parietal Cortex rTMS Stimulation - 1 Day</title>
          <description>Experiment 1&#xD;
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Parietal Cortex over 1 day</description>
        </group>
        <group group_id="E2">
          <title>Experiment 1: Parietal Cortex rTMS Stimulation - 3 Days</title>
          <description>Experiment 1&#xD;
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Parietal Cortex over 3 days</description>
        </group>
        <group group_id="E3">
          <title>Experiment 1: Parietal Cortex rTMS Stimulation - 4 Days</title>
          <description>Experiment 1&#xD;
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Parietal Cortex over 4 days</description>
        </group>
        <group group_id="E4">
          <title>Experiment 2: Parietal Cortex rTMS Stimulation - 3 Days</title>
          <description>Experiment 2&#xD;
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Parietal Cortex over 3 days</description>
        </group>
        <group group_id="E5">
          <title>Experiment 2: Vertex rTMS Stimulation - 3 Days</title>
          <description>Experiment 2&#xD;
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Vertex, over 3 days</description>
        </group>
        <group group_id="E6">
          <title>Experiment 2: Prefrontal Cortex rTMS Stimulation - 3 Days</title>
          <description>Experiment 2&#xD;
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Prefrontal Cortex, over 3 days</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="4"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="4"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>4.4</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="4"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Migraine</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="4"/>
              </event>
              <event>
                <sub_title>Intolerance to stimulation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" events="2" subjects_affected="2" subjects_at_risk="4"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Eric Wassermann</name_or_title>
      <organization>National Institutes of Health</organization>
      <phone>301-496-0151</phone>
      <email>wassermanne@ninds.nih.gov</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

